Han Kun Law Offices Law | Shanghai

Han Kun Law Offices

Legal Services | Mainland China, China

www.hankunlaw.com

tel: (86 21) 6080 0909 | fax: (86 21) 6080 0999

33/F, HKRI Center Two, HKRI Taikoo Hui, 288 Shimen Road (No. 1) | Shanghai | Mainland China | 200041 | China

Main Contacts

Offices

Han Kun Law Offices News

Monday, May 18, 2026 •Domestic Remedies for Overseas Securities Fraud: Insights from the Extraterritorial Application of the PRC Securities Law

Thursday, May 14, 2026 •China's HGR Draft Rules Signal Regulatory Easing: Key Takeaways from the Implementing Rules for the Administrative Regulation on Human Genetic Resources (Draft for Comments)

Monday, May 11, 2026 •PRC Rules on Improper Extraterritorial Jurisdiction: Key Takeaways and Implications for Foreign-invested Banks

Saturday, May 2, 2026 •China New Biomedical Technology Regulations (Order No. 818) Enter into Force – Dual-Track System for Product Registration / Clinical Translation and Application Finally Takes Effect

Wednesday, April 29, 2026 •The Arrival of the Web3 Era: Taking stock of HK Court Decisions Relating to Digital Assets

Overview

Han Kun is a leading full-service law firm in China. Over the years, Han Kun has been widely recognized as a leader in complex cross-border and domestic transactions and compliance matters.

Our main practice areas include private equity, mergers and acquisitions, international and domestic capital markets, investment funds, asset management, compliance, banking and finance, aviation finance, foreign direct investment, antitrust/competition, data protection, private client/wealth management, intellectual property, bankruptcy and restructuring and dispute resolution.

We have more than 900 professionals located in Beijing, Shanghai, Shenzhen, Hangzhou, Wuhan, Haikou, Hong Kong, Singapore, New York, Silicon Valley and London.

All our lawyers are graduates of top universities and have extensive experience in complex cross-border transactions and dispute resolution as counsel to both Chinese and foreign clients.

Our working languages include Chinese, English, Japanese, Korean and German.

Lawyers Worldwide: 900

Areas of Practice

Antitrust/Competition
Asset management
Aviation and Aviation Finance
Banking and Finance
Capital Reduction, Winding Up and Bankruptcy
Corporate Compliance
Corporate Restructuring
Cross-border arbitration and dispute resolution
Data Protection
Direct Investment
Dispute Resolution
Domestic and International Capital Markets
General corporate
Insurance
Intellectual Property
Investment Funds
Labor and Employment
Life Sciences and Healthcare
Mergers and Acquisitions
Private Equity and Venture Capital
Project finance
Real Estate and Infrastructure
Structured Finance and Asset-backed Securitization Fintech
Tax Planning
Technology, Media and Telecoms

Professionals

Partners

Yinshi Cao

Partner

Zhiyi Cao

Partner

Yijun Chao

Partner

Lei Chen

Partner

Cheng Chen

Partner

Zhen (Cody) Chen

Partner

Ying (Elaine) Cui

Partner

Yi DING

Partner

Shiwen Dong

Partner

Chao (Kelvin) Gao

partner

Yin Ge

Partner

Yaling (Michelle) Gon

Partners

Yang (Aaron) Gu

Partners

Yifan (Florine) Gu

Partner

Yao (Ally) Hu

Partner

Wei (Will) HUANG

Partner

Weiheng Jia

Partner

Wenyu Jin

Partner

Xun Li

Partner

Jun Li

Partner

Andy LIAO

Partner

Chunyao Lin

Partner

Zeda Lin

Partner

Paula LIU

Partner

Dong (Eric) Liu

Partner

Min Luo

Partner

Zhenzheng (Angela) Ni

Partners

Shuting Qi

Partner

Wei Quan

Partners

Zhaojun (Sophie) Shi

Partners

Qing (Nick) Shu

Partner

Wei Song

Partner

Jicong(Vincent) Song

Partner

Wei (Vincent) Sun

Partner

Zhihua (David) TANG

Partner

Yan Wang

Partner

Huajun Wang

Partners

Xiaoxue(Dana) Wu

Partners

Ping Xu

Partner

Jiawang (Daniel) Xu

Partner

Li Yang

Partner

Zhihao Ye

Partner

Feng Ye

Partner

Yao Zhang

Partner

Yan Zhang

Partner

Chi (Robin) Zhang

Partner

Li Zhang

Partner

Ting Zheng

Partners

Min Zhu

Partner

Of Counsel

Dalun Chen

Of Counsel

Xiao Ding

Of Counsel

Xin Du

Of Counsel

Hanpeng (Patrick) Hu

Of Counsel

Chenchen Jiang

Of Counsel

Yunjia Sun

Of Counsel

Xi (Cindy) Wang

Of Counsel

Chunzi Wang

Of Counsel

Jinli (Jolie) Yan

Of Counsel

Hua Zhong

Of Counsel

Articles

Domestic Remedies for Overseas Securities Fraud: Insights from the Extraterritorial Application of the PRC Securities Law

Han Kun Law Offices, May 2026

In 2026, the Beijing Financial Court and the High People's Court of Beijing Municipality（"Beijing High People's Court"）ruled that Chinese mainland courts had jurisdiction over securities fraud involving a Cayman Islands company listed on the Hong Kong Stock Exchange (HKEX). This landmark decision sets a precedent as the first instance in which judicial authorities in Chinese mainland applied the Securities Law of the PRC (the "Securities Law") extraterritorially. The decision is recognized as a "typical case" and has been included in theReport on the Work of the Supreme People's Court (2026)[1]...

China's HGR Draft Rules Signal Regulatory Easing: Key Takeaways from the Implementing Rules for the Administrative Regulation on Human Genetic Resources (Draft for Comments)

Han Kun Law Offices, May 2026

On May 8, 2026, the National Health Commission ("NHC") released theImplementing Rules for the Administrative Regulation on Human Genetic Resources (Draft for Comments)("Draft for Comments"), proposing amendments to the currentImplementing Rules for the Administrative Regulation on Human Genetic Resources("Current Implementing Rules") formulated by the Ministry of Science and Technology ("MOST") in 2023 (for our interpretation of the Current Implementing Rules, please see our previous article:Han Kun Perspective First Release: Key Takeaways from the Implementing Rules for the Administrative Regulation on Human Genetic Resources), and is soliciting public comments...

VIEW ALL Han Kun Law Offices Articles

Press releases

Han Kun Advises Everest Medicines in Acquiring an Exclusive License with Vcare PharmaTech for Sumecigrel, a P2Y12 receptor antagonist, in Asia-Pacific Markets

Han Kun Law Offices, June 2026

On June 9, 2026, Everest Medicines (HKEX: 1952) announced that it had entered into an agreement with Jiangsu Vcare PharmaTech Co., Ltd. ("Vcare PharmaTech"), under which Everest Medicines obtained the exclusive rights to develop, register and commercialize Sumecigrel (formerly known as Vicagrel), a P2Y12 receptor antagonist, in multiple countries and regions across Asia-Pacific, including Southeast Asia, South Korea, Australia, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan region, China...

Han Kun again recognized in MIP's IP STARS rankings

Han Kun Law Offices, June 2026

Managing Intellectual Property (MIP), a world-renowned IP publication, has recently announced its 2026 global IP STARS rankings. Han Kun was again recognized in the China domestic firm categories of "IP transactions (Tier 1)", "Patent disputes", "Trademark disputes", "Patent prosecution", and "Copyright", owing to the firm's competitive IP division and exceptional service capabilities. This is the sixth consecutive year for Han Kun to appear in the rankings, which reflects MIP's affirmation of the firm's comprehensive strength and influence.Besides these firm-level accolades, Han Kun partners Lili Wu and Yan Wang were recognized as "IP Stars" again...

VIEW ALL Han Kun Law Offices Press